PharmaCyte Biotech Inc (PMCB)

[Senior Chief]

SeeingGreen420: Yep I saw this and it is really impressive that NVLX can attract such well known professionals. For many years I have read in various investment forums what a buyout candidate this or that company is. Like most, but not all, of the posts in investment forums statements like that is just wishful thinking. In the case of NVLX if the Phase II-B clinical trials are successful and if fast tracked by the FDA I can really see NVLX being a serious buyout candidate! I have been in the market since November 1966 and I have just about seen and heard it all so I don't see things through rose colored glasses. For full disclosure I am a stockholder in NVLX with an average cost per share of $0.3723 per share. I am a long term holder but my plan is to sell half of my holdings at $0.74 per share and let the rest of my shares ride to see what happens. Sincerely, Senior Chief